NRX Pharmaceuticals, Inc. (NRXPW)

Latest Insider Confidence Score

2025Q4

50.0
Bullish

Company insider confidence (by quarter)

2017Q4 2025Q4

Largest shareholders

Insider Role (last 12 mo) Shares held Filed at
Javitt Jonathan C Chair 14,321,997 Aug 24, 2023
Javitt Daniel C. 10% Owner 9,634,793 Dec 1, 2022
B Group, Inc. — 3,000,000 Aug 21, 2025
Hurvitz Chaim Director 1,644,793 Sep 11, 2023
Nussbaum David M — 1,638,000 Nov 26, 2018

Recent buy/sell transactions

Exec date Filing date Insider Role Signal Confidence Shares % of shares Under plan? Amount (USD)
Apr 9, 2025 Sep 10, 2025 Javitt Jonathan C Chair Neutral 52.5 - 0.00% ✗ -
Apr 9, 2025 Sep 10, 2025 McBride Dennis Director Neutral 52.5 - 0.00% ✗ -
Apr 9, 2025 Sep 10, 2025 Hurvitz Chaim Director Neutral 52.5 - 0.00% ✗ -
Apr 9, 2025 Sep 10, 2025 Flynn Patrick John Director Neutral 52.5 - 0.00% ✗ -
Aug 21, 2025 B Group, Inc. 10% Owner Neutral 52.5 - 0.00% ✗ -
Feb 7, 2025 Feb 11, 2025 ABRAMS MICHAEL S CFO Neutral 52.5 - 0.00% ✗ -
Dec 17, 2024 Dec 18, 2024 Javitt Jonathan C Chair Buy 83.8 +40,000 2.71% ✗ $46.8K
Nov 22, 2024 ABRAMS MICHAEL S CFO Neutral 52.5 - 0.00% ✗ -
Jun 26, 2024 McBride Dennis Director Neutral 52.5 - 0.00% ✗ -
Jan 16, 2024 Rehnquist Janet Director Neutral 52.5 - 0.00% ✗ -
Sep 19, 2023 Narido Richard Clavano CFO Neutral 52.5 - 0.00% ✗ -
Aug 30, 2023 Sep 11, 2023 Gorovitz Aaron Director Buy 91.3 +35,000 50.00% ✗ $11.2K
Aug 30, 2023 Sep 11, 2023 Hurvitz Chaim Director Buy 83.8 +70,000 3.26% ✗ $20.1K
Aug 23, 2023 Aug 24, 2023 Javitt Jonathan C Chief Scientist Buy 68.8 +100,000 0.68% ✗ $33K
Aug 22, 2023 Aug 23, 2023 Javitt Jonathan C Chief Scientist Buy 82.5 +200,000 1.38% ✗ $64.4K
Dec 14, 2022 Feb 14, 2023 Javitt Jonathan C Director Neutral 27.5 -300,000 -2.03% ✗ -
Dec 16, 2022 Dec 19, 2022 Willard Stephen H CEO Buy 95.0 +50,000 100.00% ✗ $58.5K
Dec 16, 2022 Dec 19, 2022 VAN VOORHEES SETH CFO Buy 91.3 +30,000 183.63% ✗ $33K
Nov 25, 2022 Dec 19, 2022 VAN VOORHEES SETH CFO Buy 91.3 +16,337 100.00% ✗ $18.2K
Dec 7, 2022 Dec 9, 2022 Javitt Jonathan C Director Sell 20.0 -400,000 -2.97% ✗ $400K
Nov 29, 2022 Dec 1, 2022 Javitt Daniel C. 10% Owner Sell 53.8 -22,171 -0.23% ✓ $33.4K
Nov 28, 2022 Nov 29, 2022 Flynn Patrick John Director Buy 86.3 +11,750 8.06% ✗ $14.7K
Nov 25, 2022 Nov 28, 2022 VAN VOORHEES SETH CFO Buy 91.3 +16,337 90.40% ✗ $18.2K
Nov 16, 2022 Nov 23, 2022 Hurvitz Chaim Director Buy 97.5 +500,000 100.00% ✗ $514.9K
Oct 21, 2022 Nov 22, 2022 Gorovitz Aaron Director Neutral 52.5 - 0.00% ✗ -
Oct 21, 2022 Nov 22, 2022 Glied Sharon Director Neutral 52.5 - 0.00% ✗ -
Oct 21, 2022 Nov 22, 2022 Flynn Patrick John Director Neutral 52.5 - 0.00% ✗ -
Nov 16, 2022 Nov 21, 2022 Hurvitz Chaim Director Buy 97.5 +500,000 30.40% ✗ $514.9K
Nov 16, 2022 Nov 18, 2022 Javitt Daniel C. 10% Owner Sell 45.0 -166,737 -1.70% ✓ $171.1K
Nov 11, 2022 Nov 15, 2022 Javitt Daniel C. 10% Owner Sell 52.5 -49,200 -0.50% ✓ $49.5K
Jul 29, 2022 Aug 2, 2022 Javitt Daniel C. 10% Owner Sell 20.0 -784,063 -7.36% ✗ $791.4K
Jul 22, 2022 Willard Stephen H CEO Neutral 52.5 - 0.00% ✗ -
Jul 1, 2022 Jul 5, 2022 Javitt Daniel C. 10% Owner Neutral 27.5 -2,000,000 -15.80% ✗ -
Jun 29, 2022 VAN VOORHEES SETH CFO Neutral 52.5 - 0.00% ✗ -
Jun 3, 2022 Jun 7, 2022 Javitt Daniel C. 10% Owner Sell 20.0 -445,712 -3.40% ✗ $303.9K
Jun 1, 2022 Jun 2, 2022 Javitt Jonathan C Chief Scientist Buy 72.5 +100,000 0.68% ✗ $58K
Jun 1, 2022 Jun 2, 2022 Javitt Jonathan C Chief Scientist Buy 78.8 +100,000 0.68% ✗ $5.8M
Mar 24, 2022 Strassberg Ira S CFO Neutral 52.5 - 0.00% ✗ -
Mar 8, 2022 Mar 10, 2022 Besthof Robert CEO Neutral 52.5 - 0.00% ✗ -
Aug 26, 2021 Nov 2, 2021 McMaster Herbert Raymond Director Neutral 52.5 - 0.00% ✗ -
Jul 16, 2021 Nov 2, 2021 Javitt Daniel C. 10% Owner Neutral 27.5 -869,188 -6.22% ✗ -
Aug 19, 2021 Nov 2, 2021 Daigneault Alessandra General Counsel & Secretary Sell 20.0 -33,715 -100.00% ✗ $442K
Aug 16, 2021 Nov 2, 2021 Besthof Robert Chief Comm. & Patient Officer Sell 20.0 -40,000 -62.78% ✗ $470.4K
Nov 2, 2021 McMaster Herbert Raymond Director Neutral 52.5 - 0.00% ✗ -
May 24, 2021 Jun 10, 2021 Troy Daniel Director Neutral 90.0 +43,093 100.00% ✗ -
May 24, 2021 Jun 10, 2021 Javitt Jonathan C CEO Neutral 90.0 +14,817,329 100.00% ✗ -
May 24, 2021 Jun 10, 2021 Javitt Daniel C. 10% Owner Neutral 90.0 +13,971,864 100.00% ✗ -
May 24, 2021 Jun 10, 2021 Hurvitz Chaim Director Neutral 90.0 +1,644,793 100.00% ✗ -
May 24, 2021 Jun 10, 2021 Gorovitz Aaron Director Neutral 90.0 +41,686 100.00% ✗ -
May 24, 2021 Jun 10, 2021 Glied Sharon Director Neutral 90.0 +13,168 100.00% ✗ -
May 24, 2021 Jun 10, 2021 Fricker William CFO Neutral 52.5 - 0.00% ✗ -
May 24, 2021 Jun 10, 2021 Flynn Patrick John Director Neutral 90.0 +432,750 100.00% ✗ -
May 24, 2021 Jun 10, 2021 Daigneault Alessandra General Counsel & Secretary Neutral 90.0 +6,320 100.00% ✗ -
May 24, 2021 Jun 10, 2021 Besthof Robert Chief Comm. & Patient Officer Neutral 52.5 - 0.00% ✗ -
Jun 10, 2021 Troy Daniel Director Neutral 52.5 - 0.00% ✗ -
Jun 10, 2021 Javitt Jonathan C CEO Neutral 52.5 - 0.00% ✗ -
Jun 10, 2021 Javitt Daniel C. 10% Owner Neutral 52.5 - 0.00% ✗ -
Jun 10, 2021 Hurvitz Chaim Director Neutral 52.5 - 0.00% ✗ -
Jun 10, 2021 Gorovitz Aaron Director Neutral 52.5 - 0.00% ✗ -
Jun 10, 2021 Glied Sharon Director Neutral 52.5 - 0.00% ✗ -
Jun 10, 2021 Fricker William CFO Neutral 52.5 - 0.00% ✗ -
Jun 10, 2021 Flynn Patrick John Director Neutral 52.5 - 0.00% ✗ -
Jun 10, 2021 Daigneault Alessandra General Counsel & Secretary Neutral 52.5 - 0.00% ✗ -
Jun 10, 2021 Besthof Robert Chief Comm. & Patient Officer Neutral 52.5 - 0.00% ✗ -
May 24, 2021 Jun 4, 2021 BRAC Lending Group LLC 10% Owner Neutral 27.5 -869,565 -59.56% ✗ -
May 24, 2021 May 25, 2021 Big Rock Partners Sponsor, LLC 10% Owner Neutral 27.5 -5,435 -1.09% ✗ -
May 24, 2021 May 25, 2021 BRAC Lending Group LLC 10% Owner Neutral 27.5 -869,565 -60.72% ✗ -
Mar 13, 2020 Mar 17, 2020 Polar Asset Management Partners Inc. 10% Owner Sell 20.0 -29,464 -5.69% ✗ $312.3K
Mar 6, 2020 Polar Asset Management Partners Inc. 10% Owner Neutral 52.5 - 0.00% ✗ -
Nov 26, 2018 BRAC Lending Group LLC 10% Owner Neutral 52.5 - 0.00% ✗ -
Nov 20, 2018 Nov 20, 2018 ACKERMAN RICHARD CEO Neutral 27.5 -1,500,000 -86.96% ✗ -
Nov 29, 2017 Dec 4, 2017 ACKERMAN RICHARD CEO Buy 90.0 +22,500 9.00% ✗ $225K
Dec 4, 2017 Wittman Lori CFO Neutral 52.5 - 0.00% ✗ -
Dec 4, 2017 KIM BENNETT Chief Invt. Ofc. & Corp. Sec. Neutral 52.5 - 0.00% ✗ -
Dec 4, 2017 Taylor Troy T Director Neutral 52.5 - 0.00% ✗ -
Dec 4, 2017 REX ALBERT G. Director Neutral 52.5 - 0.00% ✗ -
Dec 4, 2017 Koenig Stuart F. Director Neutral 52.5 - 0.00% ✗ -
Dec 4, 2017 FONG MICHAEL Director Neutral 52.5 - 0.00% ✗ -
Dec 4, 2017 BIRDOFF RICHARD Director Neutral 52.5 - 0.00% ✗ -
Dec 4, 2017 ACKERMAN RICHARD CEO Neutral 52.5 - 0.00% ✗ -